Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-461076
Filing Date
2016-02-12
Accepted
2016-02-12 07:03:51
Documents
108
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d97997d10k.htm 10-K 1466843
2 EX-10.33 d97997dex1033.htm EX-10.33 26643
3 EX-10.34 d97997dex1034.htm EX-10.34 40067
4 EX-10.35 d97997dex1035.htm EX-10.35 31941
5 EX-21.1 d97997dex211.htm EX-21.1 2280
6 EX-23.1 d97997dex231.htm EX-23.1 1574
7 EX-31.1 d97997dex311.htm EX-31.1 8935
8 EX-31.2 d97997dex312.htm EX-31.2 9053
9 EX-32.1 d97997dex321.htm EX-32.1 5145
16 GRAPHIC g97997g33p87.jpg GRAPHIC 101569
  Complete submission text file 0001193125-16-461076.txt   7770095

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT vnda-20151231.xml EX-101.INS 1439564
11 XBRL TAXONOMY EXTENSION SCHEMA vnda-20151231.xsd EX-101.SCH 82288
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20151231_cal.xml EX-101.CAL 102517
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20151231_def.xml EX-101.DEF 483831
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20151231_lab.xml EX-101.LAB 591388
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20151231_pre.xml EX-101.PRE 575528
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 161414142
SIC: 2834 Pharmaceutical Preparations